Health Care M&A Deals, June 26, 2020

Health Care M&A Deals, June 26, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal announcement of the week was Invitae Corporation’s acquisition of ArcherDX, a genomic sequencing services company, for $883.3 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service... Read More »
Health Care M&A Deals, June 26, 2020

Health Care M&A Deals, June 19, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal announcement of the week was Lee Equity Partners’ acquisition of Integrated Medical Professionals and The Urology Group for and estimated $240 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious... Read More »
Health Care M&A Deals, June 26, 2020

Health Care M&A Deals, June 12, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal announcement of the week was AbbVie Inc.’s and Genmab A/S’ new broad oncology collaboration valued at $750 million. The two companies are signing a broad collaboration agreement to jointly develop and commercialize three of Genmab’s early-stage investigational bispecific antibody product candidates. To subscribe to our Health Care M&A deals chart... Read More »
Has Healthcare M&A Volume Bottomed Out?

Has Healthcare M&A Volume Bottomed Out?

The only way to go is up, right? April was the first full month after the World Health Organization declared the COVID-19 virus a pandemic on March 11, and you can see the impact in the healthcare M&A numbers. Even after adding deals that surfaced in later weeks, April 2020 deal count just barely crossed the 100 mark, according to our Deal Search Online database. With 97 deals on the books for May, it seems we have bottomed out. It might take more than a year to hit the numbers that were posted in May 2019 (175 deals), but with restrictions loosening around the country, June might show increased activity. For instance, the last week of May didn’t have a single Long-Term Care deal... Read More »
Health Care M&A Deals, June 26, 2020

Health Care M&A Deals, June 5, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include Change Healthcare, Inc.’s acquisition of PDX, Inc. for $208 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments... Read More »
Health Care M&A Deals, June 26, 2020

Health Care M&A Deals, May 29, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include a Gilead Sciences’ and Arcus Biosciences’ collaboration agreement on cancer immunotherapies for $175 million and Novavax, Inc.’s acquisition of Praha Vaccines for $167 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition... Read More »